scholarly journals Early-life nicotine or cotinine exposure produces long-lasting sleep alterations and downregulation of hippocampal corticosteroid receptors in adult mice

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Stefano Bastianini ◽  
Viviana Lo Martire ◽  
Sara Alvente ◽  
Chiara Berteotti ◽  
Gabriele Matteoli ◽  
...  

AbstractEarly-life exposure to environmental toxins like tobacco can permanently re-program body structure and function. Here, we investigated the long-term effects on mouse adult sleep phenotype exerted by early-life exposure to nicotine or to its principal metabolite, cotinine. Moreover, we investigated whether these effects occurred together with a reprogramming of the activity of the hippocampus, a key structure to coordinate the hormonal stress response. Adult male mice born from dams subjected to nicotine (NIC), cotinine (COT) or vehicle (CTRL) treatment in drinking water were implanted with electrodes for sleep recordings. NIC and COT mice spent significantly more time awake than CTRL mice at the transition between the rest (light) and the activity (dark) period. NIC and COT mice showed hippocampal glucocorticoid receptor (GR) downregulation compared to CTRL mice, and NIC mice also showed hippocampal mineralocorticoid receptor downregulation. Hippocampal GR expression significantly and inversely correlated with the amount of wakefulness at the light-to-dark transition, while no changes in DNA methylation were found. We demonstrated that early-life exposure to nicotine (and cotinine) concomitantly entails long-lasting reprogramming of hippocampal activity and sleep phenotype suggesting that the adult sleep phenotype may be modulated by events that occurred during that critical period of life.

2014 ◽  
Vol 26 (9) ◽  
pp. 613-624 ◽  
Author(s):  
G. Cruz ◽  
W. Foster ◽  
A. Paredes ◽  
K. D. Yi ◽  
M. Uzumcu

2014 ◽  
Vol 6 (1) ◽  
pp. 217-247 ◽  
Author(s):  
Janet Currie ◽  
Joshua Graff Zivin ◽  
Jamie Mullins ◽  
Matthew Neidell

2013 ◽  
Author(s):  
Janet Currie ◽  
Joshua S. Graff Zivin ◽  
Jamie Mullins ◽  
Matthew Neidell

Author(s):  
Jianxin Xiao ◽  
Muhammad Zahoor Khan ◽  
Gibson Maswayi Alugongo ◽  
Shuai Liu ◽  
Yulin Ma ◽  
...  

PLoS ONE ◽  
2021 ◽  
Vol 16 (10) ◽  
pp. e0258185
Author(s):  
Taegan A. McMahon ◽  
Shannon Fernandez-Denmark ◽  
Jeffrey M. Grim

Ivermectin is a broad-spectrum antiparasitic medicine, which is often used as a treatment for parasites or as a prophylaxis. While studies have looked at the long-term effects of Ivermectin on helminths, studies have not considered the long-term impacts of this treatment on host health or disease susceptibility. Here, we tracked the effects of early life Ivermectin treatment in Cuban tree frogs (Osteopilus septentrionalis) on growth rates, mortality, metabolically expensive organ size, and susceptibility to Batrachochytrium dendrobatidis (Bd) infection. One year after exposure, there was no effect of Ivermectin exposure on frog mass (X21 = 0.904, p = 0.34), but when tracked through the exponential growth phase (~2.5 years) the Ivermectin exposed individuals had lower growth rates and were ultimately smaller (X21 = 7.78, p = 0.005; X21 = 5.36, p = 0.02, respectively). These results indicate that early life exposure is likely to have unintended impacts on organismal growth and potentially reproductive fitness. Additionally, we exposed frogs to Bd, a pathogenic fungus that has decimated amphibian populations globally, and found early life exposure to Ivermectin decreased disease susceptibility (disease load: X21 = 17.57, p = 0.0002) and prevalence (control: 55%; Ivermectin: 22%) over 2 years after exposure. More research is needed to understand the underlying mechanism behind this phenomenon. Given that Ivermectin exposure altered disease susceptibility, proper controls should be implemented when utilizing this drug as an antiparasitic treatment in research studies.


Sign in / Sign up

Export Citation Format

Share Document